[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile]

Rev Med Chil. 2021 Dec;149(12):1687-1693. doi: 10.4067/s0034-98872021001201687.
[Article in Spanish]

Abstract

Background: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are chronic hematological disorders characterized by the overproduction of one or more mature myeloid blood cell lineages. Classical Ph-MPN are polycythemia vera (PV), essential thrombocytopenia (ET) and primary myelofibrosis (PMF).

Aim: To assess the epidemiological, clinical and diagnostic characteristics of Ph-MPN in Chile.

Material and methods: Retrospective review of medical records of all patients referred as MPN from 2012 to 2017. Patients with (9;21) translocation were excluded.

Results: Data of 462 cases with a median age of 69 years from 10 public hospitals was reviewed. ET was the most frequently Ph-MNP found. The incidence of Ph-MPN was 1.5 x 100.000 cases. The JAK2 V617F mutation study was performed in 96% of patients and only 30% had a bone marrow biopsy. Thrombotic events were observed in 29% of patients. Bleeding events were observed in 7%. Five-year overall survival was 87%.

Conclusions: ET is the most frequent Ph-MPN. The mean incidence was lower than reported in the literature, in part because of a sub diagnosis.

MeSH terms

  • Aged
  • Chile / epidemiology
  • Humans
  • Janus Kinase 2 / genetics
  • Mutation
  • Myeloproliferative Disorders* / diagnosis
  • Myeloproliferative Disorders* / epidemiology
  • Myeloproliferative Disorders* / genetics
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / epidemiology
  • Polycythemia Vera* / genetics
  • Primary Myelofibrosis* / diagnosis
  • Primary Myelofibrosis* / epidemiology
  • Primary Myelofibrosis* / genetics
  • Thrombocythemia, Essential* / diagnosis
  • Thrombocythemia, Essential* / genetics

Substances

  • Janus Kinase 2